PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More Lines of Therapy

Autoimmune hemolytic anemia

A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre) Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More Lines of Therapy Presence of Circulating Cluster of Differentiation 4 Positive 28 Null T Helper Lymphocytes(CD4+CD28-) in Patients With Autoimmune Hemolytic Anemia. A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic Anemia Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia Subcutaneous ALXN1830 in Adult Participants With Warm Autoimmune Hemolytic Anemia The Significance of Release of T-follicular Helper and T-follicular Regulatory Cells in Autoimmune Haemolytic Anemia Before and After Tratment Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Subjects With Warm Autoimmune Hemolytic Anemia (wAIHA) Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia. National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia. Treatment of Autoimmune Thrombocytopenia (AITP) Autoimmune Cytopenias : Midi-Pyrenees Registry Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment Rituximab in Auto-Immune Hemolytic Anemia One Year Hospital Data Patients With AIHA in Assiut University Hospital – Clinical Hematology Unit A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA) The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia Ibrutinib in Steroid Refractory Autoimmune Hemolytic Anemia To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA). A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP ALXN1830 in Patients With Warm Autoimmune Hemolytic Anemia Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia Role of T Follicular Helper Cells in Autoimmune Hemolytic Anemia (TFH in AIHA) Data Registry of Auto Immune Hemolytic Anemia A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia Immunopathology of Autoimmune Hemolytic Anemia